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It is well established that heart beat is triggered by electrical excitation, fol-
lowed by an increase in [Ca2þ]i and ensuing activation of myofilaments in car-
diomyocytes. This property is the basis for the regulation of the heart with
electric stimulators or chemical compounds that mediate Ca2þ signaling.
Recently, we found that microscopic heat pulses induce contractions in isolated
rat cardiomyocytes without a rise in [Ca2þ]i (Oyama, K. et al., Biochem. Bio-
phys. Res. Commun., 417, 607-612, 2012). Microscopic heat pulses produced
by focusing infrared laser beam increase temperature of the extracellular solu-
tion near cardiomyocytes. In our experiments, a microscopic heat pulse (DT =
5C for 0.5 sec) induced contractions at a basal temperature of 36C.When heat
pulses were repeatedly applied at 2.5 Hz, oscillatory contractions were
observed. In contrast to the electric field stimulation, Ca2þ transients were
not detected during the course of contraction. Moreover, we confirmed that
skinned cardiomyocytes are thermally activated in the Ca2þ-free solution. To
elucidate the molecular mechanism of thermal activation, microscopic heat
pulses were applied to an in vitro motility assay system utilizing reconstituted
thin filaments (rabbit skeletal actin filaments reconstituted with human cardiac
tropomyosin and bovine cardiac troponin). Thin filaments started to move dur-
ing heating in the absence of Ca2þ, and most of filaments immediately stopped
after switching the laser off, demonstrating that thin filaments can be thermally
activated, presumably due to the weakening of the binding affinity of the
troponin-tropomyosin complex with actin (Ishiwata, S., Biochim. Biophys.
Acta, 534, 350-357, 1978). These results suggest that heat pulses can regulate
cardiac contractions by shifting the ‘‘on-off’’ equilibrium in the thin filament
toward the ‘‘on’’ state, without accompanying intracellular Ca2þ transients.
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The first mutation found to be associated with hypertrophic cardiomyopathy
(HCM) is the R403Q mutation in the gene encoding b-myosin heavy chain.
R403Q is located in the globular head of myosin (S1), responsible for actin
interaction, and hence motor function of myosin. According to the 2-state
model of actin-myosin interaction total cross-bridge turnover rate can be
described by the sum of the cross-bridge association (fapp) and detachment
(gapp) rates. Gapp is equivalent to the slow rate of cross-bridge relaxation
(slow krel), which equals the energetic cost of tension generation, i.e. tension
cost (expressed by ATP utilization/tension). In the present study we investi-
gated to what extent cross-bridge kinetics in HCM with the R403Q mutation
correlated with cross-bridge energetics.
Left ventricular multicellular muscle strips and myofibrillar preparations were
isolated from 3 HCM patients with the R403Q mutation. 8 HCM sarcomere
mutation negative (HCMsmn) patients served as control. In the muscle strips
force generating capacity and ATP utilization were measured to assess tension
cost and in the myofibrillar preparations cross-bridge kinetics was analyzed.
The fraction of mutated R403Q mRNA was analyzed using specific restriction
digests and realtime-PCR. Compared to HCMsmn tension cost was higher in the
muscle strips of the 3 R403Q patients which showed a positive linear correla-
tion with relaxation kinetics in the corresponding myofibrillar preparations.
Variation in cross-bridge function among the 3 R403Q patients could not be
explained by differences in R403Q mRNA levels.
Cross-bridge cycling efficiency was decreased in HCM due to the R403Q mu-
tation, while cross-bridge kinetics was increased. This suggests that the
apparent gain in function evident from increased kinetics leads to a loss of func-tion with respect to cross-bridge cycling efficiency in HCM caused by the
R403Q mutation.
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Introduction: Familial hypertrophic cardiomyopathy (FHC) is a primary disease
of the sarcomere. The R403Q mutation resides at the actin-interaction site on
myosin and leads to progressive hypertrophic cardiomyopathy that can result
in sudden cardiac death or congestive heart failure. Previous studies examining
the functional impact of the R403Q mutation give inconsistent results such as
either reduced or enhanced actin-activated ATPase. We hypothesized that the
R403Q mutation intrinsically increases the energetic cost of contraction.
Methods: To do this, we assessed Ca2þ-sensitivity of tension and cross-bridge
kinetics in de-membranated cardiac trabeculae from wild-type (WT) and
R403Q hearts at 2 months of age. Assuming a two-state model of cross-
bridge binding and un-binding, we measured cross-bridge kinetics using 2
methods: (1) the rate of ATP hydrolysis (off-rate) by NADH oxidation that
is enzymatically and stoichiometrically coupled to ATP consumption, and
(2) the rate of force redevelopment (ktr; on-rate plus off-rate) by a rapid
release-restretch protocol.
Results: Male R403Q mice display a decrease in Ca2þ sensitivity (2.461mM5
0.072) compared to WT males and females (2.189 mM 5 0.059 and
2.166 mM50.044, respectively) at SL 2.0mm. R403Q males display increased
tension cost at SL 2.0mmwhen compared to WT counterparts (9.565 0.68 and
6.82 51.07 pmol s-1 mm-1 mN-1, respectively). At maximal activation, the
rate of force redevelopment (ktr) is not significantly different between
R403Q and WT males (40.2656.86 and 30.2653.95 s-1).
Conclusions: Although maximal ktr is not significantly different between WT
and R403Q males, an increase in ATP hydrolysis (off rate) suggests an alter-
ation in cross-bridge kinetics. Importantly, future studies will explore the rela-
tionship between submaximal activation and ktr. Along with no overt
pathology at 2 months, the R403Q mutation alters the energetic cost of contrac-
tion and isometric properties.
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The human hypertrophic cardiomyopathy mutation R453C is associated with a
high incidence of sudden cardiac death. We have expressed the motor domain
(MD) of human beta-myosin and the human ventricular essential light chain
(MLC3) with the R453C mutation using a mouse muscle cell line. We have
examined the binding of nucleotides to the MD and actin$MD and compared
the kinetic data to our previous study of the wild type MD (Deacon et al
2012). Little change was observed in the binding of ATP or ADP to actin$MD
but the two fluorescence changes accompanying ATP binding to MD in the
absence of actin were slower. The fast phase, previously assigned to the
conformational change accompanying tight binding of ATP to the motor,
was slowed by 30%. The slow phase,assigned to the closure of switch 2
and the recovery stroke, associated with the ATP hydrolysis step, were slowed
~ 3 fold. The R453C mutation is located in a surface loop that links the
switch-2 beta strand with the long O-helix that connects to the cardiomyopa-
thy loop in the actin binding site. R453C is therefore in a position to influence
both actin binding and switch 2 closure. The surface loop and R453 are
conserved only in sarcomeric myosins, suggesting a specific role for the
loop in muscle. Supported by NIH grants GM29090 and GM65013 and Well-
come Trust grant 085309.
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We designed a system to examine the structural properties of human b-cardiac
myosin using fluorescence spectroscopy. Expression of human b-cardiac
